期刊文献+

健脾补肾方对再生障碍性贫血患者外周血Th17及相关细胞因子水平的影响 被引量:6

Effect of the Tonifying Sleep and Kidney Treatment Method on the Peripheral Levels of Th17 and Related Cytokine in Chronic Aplastic Anemia
暂未订购
导出
摘要 目的探讨健脾补肾方对70例慢性再生障碍性贫血(CAA)患者治疗前后的调节性T细胞及白介素-6(IL-6),白介素-17(IL-17)水平差异的影响。方法收集CAA患者70例,分为对照组和治疗组,治疗组45例分为脾肾阴虚组及脾肾阳虚组,采用ELISA法检测血浆中IL-17,IL-6的水平,流式方法检测Th17水平。统计治疗前后的各指标水平变化。结果与正常组比较,CAA患者Th17及IL-6水平高于正常(P<0.05)。经健脾补肾方治疗后,脾肾阳虚组Th17及相关细胞因子均有下降(P<0.05)。脾肾阳虚组IL-16水平下降(P<0.05)。对照组Th17水平下降(P<0.05)。结论健脾补肾方对CAA患者水平Th17及其相关细胞因子变化有调节作用。 Objective To investigate the significance of the tonifying sleep and kidney treatment in those patients with chronic aplastic anemia through the peripheral levels and clinical significance of Th17 , IL-17 ,IL-6 . Methods Collect 70 patients with CAA and devided them into the treatment group and control group . The treatment group was derided into PISHENYINXU group and PISHENYANGXU group and treated them with the the tonifying sleep and kidney treatment . ELISA assay was used to determine the serum levels of IL-17, IL-6 of 70 patients with CAA and FCM was used to detect the Th17. Results The levels of Th17 and IL- 17 in CAA were higher than those in normal group (P〈0. 05). The levels of Th17 and the related cytokines in PISHENYANGXU group and the level of IL-6 in PISHENYINXU group declined. The level of Th17 in normal group declined (P〈0. 05 ). Conclusion The tonifying sleep and kidney treatment menthod may have effect on Th17 and the related cytokines.
出处 《云南中医学院学报》 2013年第3期4-7,共4页 Journal of Yunnan University of Traditional Chinese Medicine
基金 国家自然科学基金(NO:81001510)
关键词 再生障碍性贫血 白细胞介素-6 白细胞介素-17 TGF-β1 健脾补肾方 aplastic anemia Th17 IL-6 IL-17 the tonifying sleep and kidney treatment method
  • 相关文献

参考文献12

  • 1Young N S. Hematopoietic cell destruction by immune mechanism in acquired aplastic anemia[J]. Semin Hematol, 2000; 37( 1 ) : 3-14.
  • 2Young N S,Calado R T,Scheinberg P et al. Current con- cepts in the pathophysiologyand treatment of aplastic anemi- a[J]. Blood, 2006 ; 108( 8 ) : 2509-2519.
  • 3Harrington LE,Mangan PR,Weaver CT. Expanding the ef- lector CD4T- cell repertoire: the Thl7 lineage[J]. Curr Opin Immunol, 2006, 18 : 349- 356.
  • 4Shevach E M. CD4 CD25 suppressUrT cells:More questions than aIl-swels[J]. Nat Rev hnmunol, 2002,2(6) : 389-400.
  • 5Kom T,Bettelli E,Oukka M,et al. IL- 17 and Thl7 Cells [J]. Annu Rev Immunol,2009,27: 485-517.
  • 6郭振兴,郑翠玲,陈振萍,董文川,杨仁池.白介素6对人Th17细胞的免疫调节作用[J].中国实验血液学杂志,2011,19(2):496-498. 被引量:10
  • 7尹晓晓,刘传方,李丽珍,陈为志.再生障碍性贫血患者CD4^+CD25^+CD127^low调节性T细胞及Notch1表达水平的变化[J].中华血液学杂志,2008,29(5):308-311. 被引量:13
  • 8Irwin CR, Myrillas TF. The role of IL-6 in the pathogene- sis of periodontal disease[J]. Oral Dis, 1998, 4( 1 ) : 43-7.
  • 9Harrington LE, Mangan PR,Weaver CT. Expanding the ef- lector CD4 T- cell repertoire: the Thl7 lineage [J]. Curr Opin Immunol, 2006, 18 : 349- 356.
  • 10Antonysamya MA,Fanslow WC,Fu F, et al. Evidence for a role of IL-17 in organ allograft rejectionlL-17 promotes the function differentiation of dendritic cell progenitor[J]. J Immunol, 1999, 162 ( 1 ) : 577-584.

二级参考文献79

共引文献52

同被引文献69

引证文献6

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部